M&A business
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your Quote:
Plus, I believe this DECN management is incompetent
My Statement:
I guess, the same attitude had J&J and what came out of it? They learned the hard way, what a so-called incompetent Management can achieve if underrated.
Always surprised, that one can post unfiltered comments from another board whose Editor is known as a Person who has been fired by the Company and who has been involved in stealing Shares from the Company but then based on a court verdict had to return the Shares back to the Company.
That with this Action KB made enemies is obvious, but it Shows his strong Hands as CEO and for the benefit of the shareholders.
The only question I do have, what is so funny about? Backing People who stole Shares?
The UK Corner is betting on a fast outcome, means Settlement. Would be in the interest of both parties (J&J and DECN).
As I have written before: It is not about the "size of the amount" being paid it is about that J&J had to capitulate.
The way some see it: The ball is now with DECN and their advisers. They should take the offer and move ahead and by closing the litigation get some strong houses backing them for becoming a strong Player in the market.
Or as somebody said: When you refuse to settle for less than the best ....... the best tends to track you down. In short: Better to have the bird in your Hand than on the Roof.
Did not know, that Bid-Ask is part of the court documents.
Is it? Then please post here a summary of the document language.
Thank you.
Could you please Elaborate what you understand under disappointing? Did you read the court documents?
Some interesting professional questions and professional replies.
For the sake of good order: I did not ask the questions nor being part who replied to it.
Copied it before it goes under:
QUESTION: Can you tell us more about its capabilities? Internet interface? Wireless? Memory? Do you download the data later in the day? Memory stick USB interface?
ANSWER:
Let's go over these questions one at a time:
1. interface. The product has two interface modes. The first is a mobile radio module that connects to the "cloud" via a common IP address.The company is probably going to use the AT&T network but may use Sprint/Tmobile. Glucose results are transmitted from the device automatically via simple messaging system to either Apple, Android or Blackberry smart phones or similarly to regular cell phones. iPad and Android pads will also work. Presumably the phone to which the results are to be communicated belongs to a caregiver, parent, school nurse, doctor etc. The communication protocol was written by the company in 2009. There is also a wired USB interface which is a remnant..
2. Wireless. Yes, see above.
3. Memory Stick/USB: Yes. The memory "stick" is a little 8GB USB drive about the size of a postage stamp only a little thicker. Pink for little girls, blue for little boys. Assuming the wired USB interface will not be used, the Memory Card can be considered permanent.
4. Software. There is complex software that can be downloaded to a smart hone or pad. This software comes from MD@Hand. Almost all mobile devices on the market employ something like this.
Enough for one night? One last thing. The weight of the device is currently 50 gm. They want the final package delivered at 30 gm.
QUESTION:
1. Verison is not listed. Is this an oversight?
2. Will bluetooth technology be used? Many devices that need to transmit data will also use the bluetooth technology. This would allow the user to send the results directly to a close proximity personal computer where data can be stored and analyzed. One of my wife's complaints is that I leave data sheets on the bathroom sink counter which manually lists blood glucose levels. (A minor infraction to me.....major to her.) Bluetooth would eliminate that without the cloud.
3. Great to see MD@Hand being used. That was my initial interest in this company.
4. 50 gm to 30 gm. Good luck with that. L
QUESTION:
And, of course, this is for kids. This looks like a well thought-out product.. How long will it take to get FDA approved? How long will it take to start selling overseas......without FDA approval?
ANSWER:
I believe they plan to do a university sponsored clinical trial for Discretion beginning in October or November. The key to that date is the availability of the proprietary strip injector. The market for a product like Discretion is the U.S., Canada and the wealthy in some third world countries. I have spoken to KB about the marketing of this brilliant concept design and he is convinced that people in the EU would consider Discretion a gimmick or toy. The FDA will take about 11 months to approve a product for children, so I believe Canada should be the first roll-out where registration is a 9-10 week process. In fact Canada is usually a great place to concept test any product to be used in the U.S. Look for Discretion to take Canada by storm.
As for additional communication protocols, I believe they are looking to NFC not Bluetooth because of battery life concerns. They do not want to put a battery pack into the device because of weight and cost. They want Discretion to be disposable, something a grandparent would buy at a retail counter because it looks too good to pass up.
More to come I guess.
This is for Kids.
Worthwhile to have a look at. (before you ask - it is for Kids)
http://www.pharmatechdirect.com/products.html
The DECN stocks reflects the Status Quo. From this Point of view no surprise at all.
Any other Company would not be around any longer and as a matter of fact, it was never written in Stone, that they would win against J&J but they did. So it was Casino for those who financed the Company and the believe, that their legal Team would succeed.
So what is left for the market to pay Attention to DECN:
1.) Settlement
2.) What will be paid - although the amount as such is not of importance as cash has a Ratio 1 to 1. The amount being paid, will cover the legal costs DECN had to refinance and will as well feed DECN with enough cash to be in a Position to finance their new Business.
3.) Excecution of the business-plan with the new products and new Partner(s)
Once this is clear, the the market will trade DECN based on the perception how much revenues they can generate through direct deals or private Label deals.
It is not about if the Price is cheap or not it is about the opportunities and as the saying goes: Cheap opportunities are so great for those seeing it. If it would be different, then nobody would be rich.
Deep inside I have a Feeling, you do not understand the Terms well.
But then I know, It can be complicated like mixing Alpha Capital with Alpha Anstalt. Sometimes, the Little devil is hidden behind some small expressions.
You write:
I totally agree that DECN's funding options are limited to "special" deals with venture capital types and hedge funds.
MY COMMENT to this:
Based on this Observation then, I must say, DECN is in excellent Company.
I recommend to read the list of the Clients of Black-Rock the largest Hedge-fund in the world. Since Banks are only doing mortgage loans the Hedge-Fund Industry took over. And not to be forgotten: I recommend to study the deal Berkshire (W.B.) did when Goldman Sachs in 2008 had Problems.
What was the Discount then? 25 % Exactly and further added to this came Warrants in the Money. So in total more than 35 % was the deal. By DECN I have not seen this Kind of Discount.
On June the 6th I posted this:
They signed a contract with a young Korean company that has an excellent reputation with excellente performance. The latter was taken from a brochure with reference to an Expo MED2015 for Eurasia. What is Expo MED:
For 22 years, expoMED Eurasia has been the meeting place for healthcare in Turkey and the surrounding countries of Eurasia. Every year, global medical device and equipment suppliers meet with distributers and healthcare professionals from the fast growing economies of South East Europe, North Africa, Middle East, Russia and the CIS region.
I guess, one would have to admit, this Expo covers a market size that is much bigger than the USA market or spoken in terms of population: roughly 1.4 billion people.
http://www.expomedistanbul.com/en/
http://s1382.photobucket.com/user/expoMED/library/?sort=9&page=1
From my personal point of view, DECN made a very smart decision and what it means for their Business will be understood at a certain Point. By some I guess, the bells are already ringing.
READING THIS: THEN THE BELLS HAVE BEEN RINGING. EXPO IN EUROPE TO MEET EURASIA THE BIGGEST MARKET IN THE WORLD WITH A COMPANY FROM KOREA PRESENT WHO MADE A DEAL WITH DECN (some of course said then there is no deal) AND NOW DECN COMES OUT AND CONFIRMS THE FINANCING THROUGH A HEDGE-FUND FROM EUROPE. (and of course some do not like this either) Formula: 1 and 1 = 2.
Rather obvious how those contacts have been prepared and made. Bravo DECN bravo K.B. excellent. And of course, more to come.
I am very happy that they got Anstalt.
5 % of their Business is in the USA
95 % of their Business is in Europe.
That they have given green light for DECN speaks for the managment of DECN and as well for their business-plan.
Hedge-Funds have a very strict risk-control and corporate governance and by going ahead, give credibility to DECN as an USA Company who got financed by a well known European Company.
You are right: This Alpha who financed the deal has nothing to do with Alpha who reported a stake in DECN.
They are based in Vaduz - Liechtenstein and known in Europe. Could be that K.B. through his old contacts when he was working in Germany could get a hold of them.
Old Networks are always good to have.
For some to understand:
- whereby Alpha purchased an 18-month, 15% OID derivative instrument in the amount of $275,000 from the company.
This gives 9.99 % per year or lets say $ 27.500.--
Now let's say this Investments allows a velocity of 5 (Keep it low) then this would generate an income of 1.375.000.-- Keep 20 % margin = $ 275.000.--
So, those $ 27.500 pa interest would return $ 275.000 in net Profit.
Everybody can do the math what Kind of return in equity this would mean and what it would mean, if repaid and what it would mean if debt converted in equity. If this is not a excellent Business for DECN then I am glad to go back to School to study again the momentum of production versus Investment.
Based on my understanding Wallstreet and the worldwide Hedge-fund industry are not here for social welfare, but to make Money. If they would not make Money, from whom the industry would then receive the funds?
Without ALPHA DECN would not have survived versus J&J. So please explain to me, how then DECN shareholders would have benefitted without being financed in this 3 years Long struggle? By closing the Business?
I am happy that he shared the News 2 weeks after the Facts. The reason: To read those comments who said there was no deal and then to prove them wrong.
And the deal is not that bad either if and when People would understand the OID tax implications.
As read:
The Solicitor General will now end this circus that JNJ has created
.
The DECN appeal opposition brief is due this coming Wednesday the 17th, the SG's brief is due the next day the 18th. 33% chance the entire appeal is tossed the following week.
Keith Berman states: Since the fundamental premise of the latest J&J/Lifescan appeal concerns the propriety, conduct and legality of the actions and decisions of the USPTO, the United States government has joined Pharma Tech in the pursuit of its final litigation victory. The Solicitor General of the United States, Donald B. Verrilli, Jr., has filed a notice of an intention to intervene in the United States Court of Appeals for the Federal Circuit. The Office of the Solicitor General will now join the Pharma Tech attorneys to finally and thoroughly extinguish their '105 patent infringement allegations.
Mr. S further says: I would bet a steak dinner that DECN and J&J counsels will privately meet the week of June 22. Neutral location? Probably not. DECN is way ahead on points. It will show strength for DECN to go into the lion pit.
The Lion Pit is in New York. Something is always going on in New York.
Tick, tick tick. The case is not going to change very much going forward. But it is time for a DECN surprise. Too bad none of this end of case intrigue will end up in the public record.
Imagine I would be a novice and take some time to reappraise the last 3 years but not based on comments on forums but based on what is available on court papers and in some legal papers covering the case.
I would then have to say: I am very much perplex that this company survived all or better said, that DECN found investors financing them through this cycle. Based on the changes on the O/S over the last 3 years it is obvious that they got financed but not through debt but through equity so no toxic momentum in the balance sheet. This for itself would make me wonder, because it is hard to find investors backing a small company involved in a litigation struggle versus a well known AAA company. But as a matter of fact it was done and based on this I would say, those backing DECN must see something in this management others do not want to see and they must as well be of the opinion that the light at the end of the tunnel is the sun and not a train coming against them.
The cumulative findings of course speak a clear verdict: J&J lost – and lost big. It is not about the amount they will pay when I say big, they lost a case which already is part of some legal dissertations. Then it is clear that J&J offered to end this case and settle and pay – the question of course in the forums is the amount. But the amount as such is not of importance as such although, it will be big enough to make DECN one if not the only Pink company, showing such kind of cash once paid in.
Then as a novice I would as well have seen the announcement about Korea and I would say, the logical step this company has taken to open a new chapter. But then as a novice I would as well have to admit, that during those 3 crazy years the company of course was not exactly in a position to keep their time table on track and this again of course would be the confusing element. How can you issue a statement “forward looking” and then not execute? Well , as in every other business or regular over the desks from politicians: Some announcements are being fulfilled – some not and then we have some who became famous with the expression: Read my lips -. Would we then say, that the latter 2 groups have misled the people? Of course not - or as somebody smart once said: Only a Pharisee is infallible.
Based on this conclusion: If I would be new in this game, I would become a bull on DECN, but as it is known, I am in this game already for some time and guess what, I am still bullish. The dilution process which of course hurts the stock price but helps the company going through this cycle will soon come to an end. And then we will talk business – and this will include, settlement, Korea , private label deals and then some.
dankdamp Excellent presentation
In case they had such plans but never were executed, Shows me, that they are following the script of any other Company. Only make a final decision if and when Due-Dilligence gives the green light.
Without having a plan you cannot state that you have an active executive and an active executive should never fall in love with an execution just as it was part of a plan.
The following Statement was issued by a AAA Company 2 weeks ago after they presented in 2014 the Goals or objectives to be achieved in a certain Country outside the USA.
" The control of development by a local authority, through Regulation and licensing for land use changes and building could not be guaranteed. For this reason, the Management decided to withdraw from the bidding.
Yes : OTC Pink Current Information and it will stay there until all pieces fit.
http://finance.yahoo.com/news/decision-diagnostics-files-application-uplisting-132000264.html
It is like with the court case J&J versus DECN. All good things take some time. But step by step DECN moves into the right direction.
Dont worry. It will be named. And by the way, they really have an excellent Reputation - this at least is what I learned from a friend from Israel who attented the EXPO 2015.
And this Event covers more than 1.2 Billion People.
WHERE EURASIAN HEALTHCARE CONNECTS
For 22 years, expoMED Eurasia has been the meeting place for healthcare in Turkey and the surrounding countries of Eurasia. Every year, global medical device and equipment suppliers meet with distributers and healthcare professionals from the fast growing economies of South East Europe, North Africa, Middle East, Russia and the CIS region.
The next time this Event takes place, will be March 2016.
http://www.expomedistanbul.com/en/About-expoMED/
And China will be present as well. So summa summarum this Event will be the Meeting place for more than 2.2 Billion People.
Or as somebody on another board wrote:
Geostrategist Brzezinski wrote that to be on top one has to deal with the Eurasian landmass, the grand chessboard. Between Lisbon and Vladivostok where 75 percent of worlds population lives, is the place where the music plays.
Of course I know the Name of the Company. I recommend that you keept this link:
http://www.expomedistanbul.com/en/.
See you later.
What has your reply to do with what I posted: Here to read again:
You forgot to say the reason why this was done in 2011.
But there are court papers which explain exactly the Background of this RS and I would say, every other Company would have done it as well under such circumstances. But then, it benefited the shareholders.
Fantastic move by the Management in 2011.
I CANNOT SEE ANYTHING WITH REFERENCE TO UPLISTING IN MY TEXT.
By the way, on this EXPO in Spring, China was the Country of Honor.
http://view.pagetiger.com/ekspoMEDOzelGosterim/ShowPreviewEng
Guess who will be there as well in 2016. China
Well if so as some smart observer on another Forum observed, this Expo will cover a market for almost 2.5 Billion consumers.
DECN I would say understands that you must go global because the market is here and with the right pricing they certainly will challenge not only J&J but some other biggies as well.
Just to put into perspective of what we are talking about:
The global blood glucose monitoring devices market is expected to reach a value of $12.2 billion in 2017, with a predicted CAGR of 4.5% between 2010 and 2017. The blood glucose test strips market segment is expected to be valued at $10.9 billion in 2017 and is forecast to exhibit a CAGR of 4.6% between 2010 and 2017. High Prevalence of Diabetes is Leading to Patients Opting for Blood Glucose Monitoring Devices
I assume, that DECN will do what the biggies are doing already, give a new developed and well designed Monitoring Device away for free and go for the Strips market, estimated to reach 10.9 Billion in 2017. The world is open, they just have to penetrate it with the right Distributors on one Hand and on the other Hand through private Label deals. 1 % Market Share already would mean: 109 Mio Revenues or 20 Mio net Profit - but then in an open global market, 1 % can only be the start.
They signed a contract with a young Korean company that has an excellent reputation with excellente performance. The latter was taken from a brochure with reference to an Expo MED2015 for Eurasia. What is Expo MED:
For 22 years, expoMED Eurasia has been the meeting place for healthcare in Turkey and the surrounding countries of Eurasia. Every year, global medical device and equipment suppliers meet with distributers and healthcare professionals from the fast growing economies of South East Europe, North Africa, Middle East, Russia and the CIS region.
I guess, one would have to admit, this Expo covers a market size that is much bigger than the USA market or spoken in terms of population: roughly 1.4 billion people.
http://www.expomedistanbul.com/en/
http://s1382.photobucket.com/user/expoMED/library/?sort=9&page=1
From my personal point of view, DECN made a very smart decision and what it means for their Business will be understood at a certain Point. By some I guess, the bells are already ringing.
You forgot to say the reason why this was done in 2011.
But there are court papers which explain exactly the Background of this RS and I would say, every other Company would have done it as well under such circumstances. But then, it benefited the shareholders.
Fantastic move by the Management in 2011.
Never - would not make sense
As you write: Smoke, mirrors and innuendo. I agree, this is what the whole court case was all about.
Johnson and Johnson would say today: We should have listened to People who understand Business and law and never listened to People who preached the Gospel: Smoke, mirrors and innuendo.
By doing so, J&J would have saved millions and would not be in a Position to ask DECN to negotiate.
Can you explain to me what it means:
Even when you win you lose?
I suggest you call the Company for guidance.
However, the Company is rather restrictive as one has seen with the News from Korea. Butthere is more to come.
May I suggest, that you print all court papers from the saga J&J / Lifescan versus DECN. If you do , I would say then you would understand why certain delays took place.
As a matter of fact, it is even stipulated in some of the courtpapers why DECN could not move Forward.
But if you seek you really shall find: who approached DECN for Settlement?
Thanks for reply
Well the word "we anticipate" and "intent" means what it says:
We anticipate a universe, where we are the only participant, generating about $75,000,000 in annual revenues and $15 million in annual profits, all low hanging fruit, available for us to seize through this social media campaign. We intend to capture all of it."
Bermans Statement from November 5, 2014 is not different from Statements made by other CEO's or politicians. This is a Forward looking Statements and as we all know, in between a lot of things may happen, that time schedules become streteched due to unforseen envents. . But there is a difference between being active or passive and DECN despite various setbacks is on the move.
With the tailwind of the Koreans DECN may indeed conquer the market and grab an attractive slice out of the cake. And what is actually $ 75 Mio in Revenues from the Overall turnover in this market?
Taking this Statement:
The global blood glucose monitoring devices market is expected to reach a value of $12.2 billion in 2017, with a predicted CAGR of 4.5% between 2010 and 2017. The blood glucose test strips market segment is expected to be valued at $10.9 billion in 2017 and is forecast to exhibit a CAGR of 4.6% between 2010 and 2017. High Prevalence of Diabetes is Leading to Patients Opting for Blood Glucose Monitoring Devices
As can be seen, even in a Statement from a world-known Organisation, the wording is "expected" which is a synonym of "anticipate" and if I take the $ 10.9 Billion figure from this forecast as Basis to the expectation of K.B. then we are talking about 0.7% market share. I would say, nobody can say that KB exaggerated on the contrary.
Korea does not make sense? Please enlighten me what you mean with that.
An excellent step into the right direction and I would guess there is more to come